Literature DB >> 8155214

Evaluation of the possibilities for preventing congenital toxoplasmosis.

W Foulon1, A Naessens, M P Derde.   

Abstract

Little is known about the best way to prevent congenital toxoplasmosis. Until recently, the major effort was directed at preventing the disease during pregnancy by the application of hygienic measures (primary prevention). With the advent of detecting congenital toxoplasmosis antenatally, another method for reducing the incidence of congenital toxoplasmosis becomes possible (secondary prevention). In this study, we evaluate these two methods for the prevention of congenital toxoplasmosis. For 12 consecutive years, we studied the incidence of congenital toxoplasmosis in 11,286 consecutive pregnant women. The impact of primary prevention was studied by measuring the reduction in seroconversion when hygienic measures were systematically applied. Primary prevention reduces the seroconversion rate during pregnancy by 63% (P = 0.013). The effect of secondary prevention was studied in 76 pregnant women at risk of delivering a child with congenital toxoplasmosis. Secondary prevention by means of serological screening combined with prenatal diagnosis detected congenital toxoplasmosis correctly in eight infected fetuses. Secondary prevention reduced the incidence of congenital toxoplasmosis an additional 40%. This reduction would predominantly be seen in the group of mildly to severely affected fetuses. From this study, the effectiveness of primary prevention is obvious. Health education on how to avoid toxoplasmosis during pregnancy should become standard obstetric care. Adequate serological screening and prenatal diagnosis can be helpful in reducing further the incidence of congenital toxoplasmosis. Whether or not screening for toxoplasmosis during pregnancy should be combined with primary prevention depends on the importance of congenital toxoplasmosis as a health problem in a given geographic area.

Entities:  

Mesh:

Year:  1994        PMID: 8155214     DOI: 10.1055/s-2007-994537

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  19 in total

1.  Toxoplasmosis seroprevalence in relation to knowledge and practice among pregnant women in Dhahran, Saudi Arabia.

Authors:  Salah H Elsafi; Wasaef F Al-Mutairi; Khalid M Al-Jubran; Mohamed M Abu Hassan; Eidan M Al Zahrani
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

2.  Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women.

Authors:  P A Jenum; B Stray-Pedersen; K K Melby; G Kapperud; A Whitelaw; A Eskild; J Eng
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 3.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

4.  Causes and frequency of blindness in patients with intraocular inflammatory disease.

Authors:  A Rothova; M S Suttorp-van Schulten; W Frits Treffers; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

5.  Toxoplasmosis during pregnancy: a case report and review of the literature.

Authors:  C Giannoulis; B Zournatzi; A Giomisi; E Diza; I Tzafettas
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

6.  Toxoplasmosis awareness, seroprevalence and risk behavior among pregnant women in the Gampaha district, Sri Lanka.

Authors:  Nilmini Chandrasena; Rasika Herath; Nawamalika Rupasinghe; Buddhini Samarasinghe; Hasaranga Samaranayake; Anuradhani Kastuririratne; Nilanthi Renuka de Silva
Journal:  Pathog Glob Health       Date:  2016-04-19       Impact factor: 2.894

Review 7.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

8.  Seroepidemiology and risk factors of Toxoplasma gondii infection in undergraduate university female students in Jordan.

Authors:  M M Obaidat; N A Al-Sheyab; A E Bani Salman; S Q Lafi
Journal:  Epidemiol Infect       Date:  2014-12-29       Impact factor: 4.434

9.  Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.

Authors:  Eileen Stillwaggon; Christopher S Carrier; Mari Sautter; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-27

Review 10.  Prenatal education for congenital toxoplasmosis.

Authors:  Simona Di Mario; Vittorio Basevi; Carlo Gagliotti; Daniela Spettoli; Gianfranco Gori; Roberto D'Amico; Nicola Magrini
Journal:  Cochrane Database Syst Rev       Date:  2015-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.